Suppr超能文献

新型冠状病毒肺炎管理中的当前有效治疗方法

Current Effective Therapeutics in Management of COVID-19.

作者信息

Atluri Kavya, Aimlin Iris, Arora Shitij

机构信息

Department of Bioinformatics, University of California, Los Angeles, CA 90095, USA.

Department of Internal Medicine, Montefiore Medical Center, New York, NY 10467, USA.

出版信息

J Clin Med. 2022 Jul 1;11(13):3838. doi: 10.3390/jcm11133838.

Abstract

The current pandemic due to the SARS-CoV-2 virus has caused irreparable damage globally. High importance is placed on defining current therapeutics for Coronavirus Disease 2019 (COVID-19). In this review, we discuss the evidence from pivotal trials that led to the approval of effective therapeutics in the treatment and prevention of COVID-19. We categorize them as effective outpatient and inpatient management strategies The review also attempts to contextualize the efficacy of therapeutics to the emerging variants. Vaccines, which remain the most effective prevention against hospitalization and deaths is not included in this review.

摘要

由严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)引发的当前大流行在全球造成了无法弥补的损害。确定2019冠状病毒病(COVID-19)的现有治疗方法至关重要。在本综述中,我们讨论了关键试验的证据,这些证据促成了治疗和预防COVID-19有效疗法的批准。我们将它们归类为有效的门诊和住院管理策略。本综述还试图将疗法的疗效与新出现的变体联系起来。本综述不包括疫苗,疫苗仍是预防住院和死亡最有效的手段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5ca/9267414/67d84ff8af97/jcm-11-03838-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验